Biotech SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares June 18, 2026
Biotech PLEOPHARMA TO PRESENT NEWDATA ON CANNABIS WITHDRAWAL In PATIENTS WITH CANNABIS USE DISORDER AND PHASE 2 PP-01 RESULTS AT THE COLLEGE ON PROBLEMS OF DRUG DEPENDENCE 88TH ANNUAL SCIENTIFIC MEETING June 17, 2026
Biotech Bio Vanillin Market to Reach USD 485.5 Million by 2036 Amid Rising Demand for Natural Flavors and Clean-Label Food Ingredients | Future Market Insights June 16, 2026
Biotech Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting June 15, 2026
Biotech Angel Yeast Releases 2025 Sustainability Report as Company Marks 40th Anniversary June 13, 2026
Biotech Roche’s VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies June 12, 2026
Biotech Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders June 11, 2026
Biotech IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants June 10, 2026
Biotech Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT® in Aggressive Brain Cancer (Glioblastoma) June 9, 2026